$100m Chelsea man wants his way out of Chelsea plans despite teammate supporting him

$100m Chelsea man wants his way out of Chelsea plans despite teammate supporting him

In spite of how it has seemed at times this season, Chelsea has a number of excellent attackers vying for playing time.

Raheem Sterling is getting enormous pay but isn’t getting any better, while Cole Palmer wants to play on the right. Nicolas Jackson looks much better on the left wing and has truly cemented himself as a striker. At last, Noni Madueke is stepping out on his own. When he returns, Christopher Nkunku ought to change everything.

And that’s all before you take into account the incredible talent we have at the academy, on loan, or perhaps acquire this summer.

There is one individual missing: Mykhailo Mudryk. He has not been treated well during the past few weeks. Mudryk has done the opposite in a manner that is nearly identical to how Madueke utilized his run of games on the squad to his advantage.

Two trains traveling in opposing directions

Due to injuries limiting the alternatives for the rest of the team, both have started out wide on a regular basis, both in their preferred position. Madueke has advanced significantly, but Mudryk did not seize the chance, and his recent performance has only strengthened the belief among the majority of people that he is not capable of succeeding—either now or in the future.

At last, the team has found its rhythm and is scoring goals. However, Mudryk has just one goal and often extended periods of complete inefficiency throughout his run of seven starts.

The club finds it difficult to do anything but keep trying because of the amount of money spent in him, but even in the best of situations, he feels like he belongs on the reserve squad, even though he occasionally shows flashes of brilliance.

Consider this: Would Mudryk be on the team if his price had been £10 million instead of £100 million? Or would he be on loan at Strasbourg?

Related articles

Share article

Latest articles

Newsletter

Subscribe to stay updated.